Altana achieved double-digit growth in the first half of 2021. In the first six months of the year, the specialty chemicals group’s sales rose by 24 percent to 1,334 million euros compared to the same period of the previous year (1,078 million euros), which was significantly influenced by the coronavirus pandemic . The sales increase was driven by strong demand for Altana solutions in almost all sales segments. Adjusted for acquisition and exchange‑rate effects, sales were up by 26 percent. Earnings before interest, taxes, depreciation, and amortization (EBITDA) increased to 283 million euros, 40 percent above the previous year’s figure (202 million euros). Owing to demand, the EBITDA margin reached 21.2 percent in the first half of 2021, thus exceeding the company’s long‑term target range of 18 to 20 percent and the same period of 2020 (18.7 percent). In the first six months, the company once again spent a considerable amount on research and development, over 80 million...
Comments
Post a Comment